News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
884,100 Results
Type
Article (88796)
Company Profile (816)
Press Release (794466)
Multimedia
Podcasts (238)
Webinars (35)
Section
Business (233598)
Career Advice (4162)
Deals (39989)
Drug Delivery (177)
Drug Development (91716)
Employer Resources (207)
FDA (18555)
Job Trends (17487)
News (398749)
Policy (40015)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (4)
2027 Genetown Standard (5)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (3054)
Academic (2)
Accelerated approval (58)
ADA (49)
Adcomms (40)
Allergies (207)
Alliances (56990)
ALS (237)
Alzheimer's disease (1973)
Antibody-drug conjugate (ADC) (555)
Approvals (18902)
Artificial intelligence (874)
ASCO (345)
Autoimmune disease (363)
Automation (64)
Bankruptcy (407)
Best Places to Work (12635)
BIOSECURE Act (23)
Biosimilars (248)
Biotechnology (480)
Bladder cancer (211)
Brain cancer (85)
Breast cancer (840)
Cancer (6608)
Cardiovascular disease (557)
Career advice (3597)
Career pathing (52)
CAR-T (386)
CDC (76)
Celiac Disease (3)
Cell therapy (1075)
Cervical cancer (54)
Clinical research (79077)
Collaboration (2378)
Commercialization (1)
Company closure (8)
Compensation (1520)
Complete response letters (106)
COVID-19 (3042)
CRISPR (125)
C-suite (1290)
Cystic fibrosis (167)
Data (8762)
Decentralized trials (3)
Denatured (91)
Depression (196)
Dermatology (97)
Diabetes (709)
Diagnostics (7602)
Digital health (70)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (429)
Drug pricing (246)
Drug shortages (39)
Duchenne muscular dystrophy (319)
Earnings (102491)
Editorial (78)
Employer branding (25)
Employer resources (174)
Events (138728)
Executive appointments (1195)
FDA (22639)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (20)
Frontotemporal dementia (36)
Funding (1950)
Gene editing (273)
Generative AI (90)
Gene therapy (851)
GLP-1 (1286)
Government (5562)
Grass and pollen (8)
Guidances (420)
Healthcare (21265)
Hematology (198)
HIV (96)
Huntington's disease (64)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (115)
Immunology and inflammation (354)
Immuno-oncology (116)
Indications (209)
Infectious disease (3443)
Inflammatory bowel disease (242)
Inflation Reduction Act (17)
Influenza (149)
Intellectual property (324)
Interviews (821)
IPO (18003)
IRA (61)
Job creations (5209)
Job search strategy (2871)
JPM (73)
Kidney cancer (23)
Labor market (122)
Layoffs (687)
Leadership (53)
Legal (10171)
Liver cancer (111)
Longevity (37)
Lung cancer (875)
Lymphoma (477)
Machine learning (67)
Management (66)
Manufacturing (1228)
Marketing (1)
MASH (226)
Medical affairs (1)
Medical device (15282)
Medtech (15445)
Mergers & acquisitions (23295)
Metabolic disorders (1834)
mRNA (269)
Multiple sclerosis (205)
NASH (24)
Neurodegenerative disease (510)
Neuropsychiatric disorders (130)
Neuroscience (3731)
Neurotech (2)
NextGen: Class of 2026 (7716)
Non-profit (5146)
Now hiring (80)
Obesity (874)
Opinion (374)
Ovarian cancer (245)
Pain (286)
Pancreatic cancer (355)
Parkinson's disease (418)
Partnered (40)
Patents (659)
Patient recruitment (767)
Peanut (71)
People (68020)
Pharmaceutical (136)
Pharmacy benefit managers (37)
Phase 1 (24445)
Phase 2 (34351)
Phase 3 (25829)
Pipeline (9829)
Policy (398)
Postmarket research (3560)
Preclinical (10989)
Press Release (72)
Prostate cancer (350)
Psychedelics (70)
Radiopharmaceuticals (373)
Rare diseases (1274)
Real estate (7462)
Recruiting (81)
Regulatory (30414)
Reports (77)
Research institute (2771)
Resumes & cover letters (654)
Rett syndrome (43)
RNA editing (30)
RSV (98)
Schizophrenia (197)
Series A (328)
Series B (239)
Service/supplier (28)
Sickle cell disease (128)
Special edition (32)
Spinal muscular atrophy (190)
Sponsored (55)
Startups (4372)
State (2)
Stomach cancer (21)
Supply chain (148)
Tariffs (104)
The Weekly (144)
Vaccines (1312)
Venture capital (134)
Weight loss (600)
Women's health (142)
Worklife (24)
Date
Today (113)
Last 7 days (618)
Last 30 days (3020)
Last 365 days (33254)
2026 (16463)
2025 (33218)
2024 (38123)
2023 (42564)
2022 (53928)
2021 (58720)
2020 (57663)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1297)
Alabama (102)
Alaska (7)
Arizona (405)
Arkansas (16)
Asia (52315)
Australia (9195)
California (14416)
Canada (4022)
China (1583)
Colorado (621)
Connecticut (642)
Delaware (448)
Europe (120655)
Florida (2143)
Georgia (467)
Hawaii (4)
Idaho (70)
Illinois (1256)
India (104)
Indiana (667)
Iowa (25)
Japan (599)
Kansas (144)
Kentucky (57)
Louisiana (64)
Maine (89)
Maryland (1750)
Massachusetts (10552)
Michigan (423)
Minnesota (804)
Mississippi (7)
Missouri (164)
Montana (37)
Nebraska (30)
Nevada (154)
New Hampshire (92)
New Jersey (3825)
New Mexico (35)
New York (3796)
North Carolina (1941)
North Dakota (11)
Northern California (7169)
Ohio (450)
Oklahoma (27)
Oregon (55)
Pennsylvania (2839)
Puerto Rico (31)
Rhode Island (55)
South America (1668)
South Carolina (88)
South Dakota (2)
Southern California (5658)
Tennessee (229)
Texas (2349)
United States (51613)
Utah (430)
Vermont (1)
Virginia (367)
Washington D.C. (89)
Washington State (1188)
West Virginia (4)
Wisconsin (160)
Wyoming (2)
There are 884,100 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cingulate Issued First U.S. Patent for Lead ADHD Asset CTx-1301
June 16, 2026
·
6 min read
Press Releases
Sanuwave Health Updates Second Quarter 2026 Guidance
June 16, 2026
·
3 min read
Press Releases
ConSynance Therapeutics Announces First Patient Dosed in Phase 2a Clinical Trial of CSTI-500 for Prader-Willi Syndrome
June 16, 2026
·
4 min read
Press Releases
Calidi Biotherapeutics Receives Positive Pre-IND Feedback from US FDA for CLD-401 Indicating Agreement on its Current Development Strategy as it Advances Towards a First-in-Human Study
June 16, 2026
·
4 min read
Press Releases
Inspire Medical Systems, Inc. Announces Presence at SLEEP 2026 and Publication of PREDICTOR Study
June 16, 2026
·
8 min read
Press Releases
BioAge Labs Announces First Participant Dosed in QUELL-CV, a Phase 2 Proof-of-Concept Trial of BGE-102, a Novel Oral NLRP3 Inhibitor, in Patients at Elevated Cardiovascular Risk
June 16, 2026
·
8 min read
Press Releases
Outlook Therapeutics Announces FDA Acceptance of Resubmitted Biologics License Application for ONS-5010/LYTENAVA™ (bevacizumab-vikg) as a Treatment for Wet AMD
June 16, 2026
·
5 min read
Press Releases
Cognition Therapeutics Announces New Composition of Matter Patent, Extending Patent Protection for Lead Candidate, Zervimesine (CT1812) Through 2045
June 16, 2026
·
7 min read
Press Releases
Acumen Pharmaceuticals Announces Nomination of Two Enhanced Brain Delivery™ (EBD™) Development Candidates for the Treatment of Alzheimer’s Disease
June 16, 2026
·
7 min read
Rare diseases
Mirum, Incyte bolster case for approval in rare bone disease despite mid-stage miss
While falling short of statistical significance, Incyte and Mirum Pharmaceuticals’ ALK2 inhibitor showed a “clear benefit” in reducing abnormal bone formation in a Phase 2 study of fibrodysplasia ossificans progressiva.
June 16, 2026
·
2 min read
·
Tristan Manalac
1 of 88,410
Next
